Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease

[41] Vlahou A(2015)Apolipoprotein B, the villain in the drama? Eur J Pharmacol 748 166-678

[42] Mischak H(2006)The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy—a review of the evidence J Intern Med 259 493-S37

[43] Hou LN(2001)High apolipoprotein B, low apolipoprotein A–I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2026-19421

[44] Li F(2004)Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study Lancet 364 937-12008

[45] Zeng QC(2015)Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case–control study Metab Brain Dis 30 1319-10

[46] Su L(2009)Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy J Am Coll Cardiol 54 930-579

[47] Chen PA(2012)RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing Nat Med 18 766-372

[48] Xu ZH(2014)Familial Mediterranean fever gene mutations as a risk factor for early coronary artery disease Int J Rheum Dis 20 2113-524

[49] Zhu DJ(2007)Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa J Pediatr 151 675-425

[50] Liu CH(2003)MEFV mutations are increased in Behcet’s disease (BD) and are associated with vascular involvement Clin Exp Rheumatol 21 S35-2414

[41] Vlahou A(2015)Apolipoprotein B, the villain in the drama? Eur J Pharmacol 748 166-678

[42] Mischak H(2006)The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy—a review of the evidence J Intern Med 259 493-S37

[43] Hou LN(2001)High apolipoprotein B, low apolipoprotein A–I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study Lancet 358 2026-19421

[44] Li F(2004)Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study Lancet 364 937-12008

[45] Zeng QC(2015)Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case–control study Metab Brain Dis 30 1319-10

[46] Su L(2009)Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy J Am Coll Cardiol 54 930-579

[47] Chen PA(2012)RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing Nat Med 18 766-372

[48] Xu ZH(2014)Familial Mediterranean fever gene mutations as a risk factor for early coronary artery disease Int J Rheum Dis 20 2113-524

[49] Zhu DJ(2007)Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa J Pediatr 151 675-425

[50] Liu CH(2003)MEFV mutations are increased in Behcet’s disease (BD) and are associated with vascular involvement Clin Exp Rheumatol 21 S35-2414